Drug Shortage Report for BREVIBLOC INJECTION 10MG/ML
| Report ID | 126749 |
| Drug Identification Number | 02188880 |
| Brand name | BREVIBLOC INJECTION 10MG/ML |
| Common or Proper name | BREVIBLOC INJECTION 10MG/ML |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | ESMOLOL HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 25 units/case |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-10-20 |
| Actual start date | 2020-10-20 |
| Estimated end date | 2020-11-09 |
| Actual end date | 2020-11-09 |
| Shortage status | Resolved |
| Updated date | 2020-11-10 |
| Company comments | Baxter product BREVIBLOC Injection esmolol hydrochloride Solution, 10 mg/mL (2500 mg/250 mL bags) (DIN: 02309238) is available as an alternative if it aligns with clinical practice. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-11-10 | English | Compare |
| v5 | 2020-11-09 | French | Compare |
| v4 | 2020-11-09 | English | Compare |
| v3 | 2020-10-21 | English | Compare |
| v2 | 2020-10-20 | French | Compare |
| v1 | 2020-10-20 | English | Compare |
Showing 1 to 6 of 6